A detailed history of Fieldpoint Private Securities, LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Fieldpoint Private Securities, LLC holds 10,241 shares of FOLD stock, worth $100,771. This represents 0.03% of its overall portfolio holdings.

Number of Shares
10,241
Previous 10,270 0.28%
Holding current value
$100,771
Previous $97,000 13.4%
% of portfolio
0.03%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 05, 2022

SELL
$6.23 - $11.12 $180 - $322
-29 Reduced 0.28%
10,241 $110,000
Q4 2021

Jan 24, 2022

BUY
$9.82 - $12.44 $31,041 - $39,322
3,161 Added 44.46%
10,270 $119,000
Q2 2021

Aug 12, 2021

SELL
$8.71 - $10.72 $757 - $932
-87 Reduced 1.21%
7,109 $74,000
Q1 2021

Apr 23, 2021

BUY
$9.2 - $23.86 $66,203 - $171,696
7,196 New
7,196 $71,000

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.76B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Fieldpoint Private Securities, LLC Portfolio

Follow Fieldpoint Private Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fieldpoint Private Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fieldpoint Private Securities, LLC with notifications on news.